Efficacy report of a multicenter phase II trial testing a biologic-only combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer (BC): A Phase II Consortium (P2C) study

Abstract only

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 26; no. 15_suppl; p. 4522
Main Authors:	Holen, K. D., Mahoney, M. R., LoConte, N. K., Szydlo, D. W., Picus, J., Maples, W. J., Kim, G. P., Pitot, H. C., Philip, P. A., Thomas, J. P., Erlichman, C. E.
Format:	Journal Article
Language:	English
Published:	20-05-2008
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!